Hogy Medical Co.,Ltd. (HGYMF)
USD 24.34
(0.0%)
USD 24.34
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 39.1 Billion JPY | 13226.06% |
| 2023 | 293.4 Million JPY | -2.89% |
| 2022 | 302.13 Million JPY | -8.54% |
| 2021 | 330.35 Million JPY | -4.21% |
| 2020 | 344.88 Million JPY | 4.13% |
| 2019 | 331.19 Million JPY | -4.59% |
| 2018 | 347.13 Million JPY | 4.94% |
| 2017 | 330.78 Million JPY | 1.67% |
| 2016 | 325.35 Million JPY | -99.08% |
| 2015 | 35.23 Billion JPY | 1.26% |
| 2014 | 34.79 Billion JPY | 5.13% |
| 2013 | 33.09 Billion JPY | 3.83% |
| 2012 | 31.87 Billion JPY | 1.79% |
| 2011 | 31.31 Billion JPY | -0.09% |
| 2010 | 31.33 Billion JPY | 1.06% |
| 2009 | 31 Billion JPY | 6.89% |
| 2008 | 29.01 Billion JPY | 6.29% |
| 2007 | 27.29 Billion JPY | 3.25% |
| 2006 | 26.43 Billion JPY | 5.9% |
| 2005 | 24.96 Billion JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q4 | 9.34 Billion JPY | 12806.17% |
| 2024 FY | 39.1 Billion JPY | 13226.06% |
| 2024 Q1 | 67.05 Million JPY | -5.69% |
| 2024 Q2 | 65.96 Million JPY | -1.63% |
| 2024 Q3 | 72.41 Million JPY | 9.78% |
| 2023 Q4 | 71.1 Million JPY | -9.76% |
| 2023 Q1 | 69.56 Million JPY | -5.57% |
| 2023 FY | 293.4 Million JPY | -2.89% |
| 2023 Q3 | 78.78 Million JPY | 16.94% |
| 2023 Q2 | 67.37 Million JPY | -3.16% |
| 2022 Q4 | 73.67 Million JPY | -14.17% |
| 2022 Q3 | 85.83 Million JPY | 5.77% |
| 2022 FY | 302.13 Million JPY | -8.54% |
| 2022 Q1 | 80.14 Million JPY | -99.09% |
| 2022 Q2 | 81.15 Million JPY | 1.26% |
| 2021 Q2 | 9.35 Billion JPY | 11.72% |
| 2021 Q1 | 8.37 Billion JPY | -8.68% |
| 2021 Q3 | 9.96 Billion JPY | 6.45% |
| 2021 FY | 330.35 Million JPY | -4.21% |
| 2021 Q4 | 8.8 Billion JPY | -11.58% |
| 2020 Q3 | 9.68 Billion JPY | 3.62% |
| 2020 FY | 344.88 Million JPY | 4.13% |
| 2020 Q1 | 9.03 Billion JPY | 3.94% |
| 2020 Q4 | 9.17 Billion JPY | -5.25% |
| 2020 Q2 | 9.34 Billion JPY | 3.36% |
| 2019 FY | 331.19 Million JPY | -4.59% |
| 2019 Q1 | 9.05 Billion JPY | 2.97% |
| 2019 Q2 | 9.18 Billion JPY | 1.46% |
| 2019 Q3 | 9.72 Billion JPY | 5.88% |
| 2019 Q4 | 8.69 Billion JPY | -10.59% |
| 2018 Q4 | 8.79 Billion JPY | -9.35% |
| 2018 Q3 | 9.69 Billion JPY | 4.65% |
| 2018 Q2 | 9.26 Billion JPY | 1.19% |
| 2018 Q1 | 9.15 Billion JPY | 1.01% |
| 2018 FY | 347.13 Million JPY | 4.94% |
| 2017 FY | 330.78 Million JPY | 1.67% |
| 2017 Q2 | 9.25 Billion JPY | 2.21% |
| 2017 Q1 | 9.05 Billion JPY | -4.81% |
| 2017 Q3 | 9.48 Billion JPY | 2.45% |
| 2017 Q4 | 9.06 Billion JPY | -4.38% |
| 2016 Q2 | 9.01 Billion JPY | 4.33% |
| 2016 FY | 325.35 Million JPY | -99.08% |
| 2016 Q3 | 9.4 Billion JPY | 4.33% |
| 2016 Q4 | 9.51 Billion JPY | 1.17% |
| 2016 Q1 | 8.63 Billion JPY | -0.71% |
| 2015 Q2 | 8.83 Billion JPY | 5.25% |
| 2015 Q1 | 8.39 Billion JPY | 0.16% |
| 2015 Q3 | 9.29 Billion JPY | 5.16% |
| 2015 FY | 35.23 Billion JPY | 1.26% |
| 2015 Q4 | 8.7 Billion JPY | -6.39% |
| 2014 Q4 | 8.38 Billion JPY | -10.33% |
| 2014 FY | 34.79 Billion JPY | 5.13% |
| 2014 Q3 | 9.35 Billion JPY | 7.66% |
| 2014 Q2 | 8.68 Billion JPY | 3.76% |
| 2014 Q1 | 8.37 Billion JPY | 6.08% |
| 2013 FY | 33.09 Billion JPY | 3.83% |
| 2013 Q3 | 8.88 Billion JPY | 7.38% |
| 2013 Q4 | 7.89 Billion JPY | -11.21% |
| 2013 Q1 | 8.04 Billion JPY | 3.14% |
| 2013 Q2 | 8.27 Billion JPY | 2.94% |
| 2012 Q3 | 8.24 Billion JPY | 3.08% |
| 2012 FY | 31.87 Billion JPY | 1.79% |
| 2012 Q1 | 7.83 Billion JPY | 5.63% |
| 2012 Q4 | 7.79 Billion JPY | -5.43% |
| 2012 Q2 | 7.99 Billion JPY | 2.03% |
| 2011 Q2 | 7.94 Billion JPY | 3.15% |
| 2011 Q3 | 8.23 Billion JPY | 3.65% |
| 2011 FY | 31.31 Billion JPY | -0.09% |
| 2011 Q1 | 7.7 Billion JPY | 3.66% |
| 2011 Q4 | 7.42 Billion JPY | -9.93% |
| 2010 Q1 | 7.81 Billion JPY | 5.26% |
| 2010 Q3 | 8.06 Billion JPY | 0.39% |
| 2010 Q2 | 8.02 Billion JPY | 2.71% |
| 2010 FY | 31.33 Billion JPY | 1.06% |
| 2010 Q4 | 7.43 Billion JPY | -7.78% |
| 2009 Q2 | 7.8 Billion JPY | 0.0% |
| 2009 FY | 31 Billion JPY | 6.89% |
| 2009 Q3 | 8.25 Billion JPY | 5.74% |
| 2009 Q4 | 7.42 Billion JPY | -10.03% |
| 2008 FY | 29.01 Billion JPY | 6.29% |
| 2007 FY | 27.29 Billion JPY | 3.25% |
| 2006 FY | 26.43 Billion JPY | 5.9% |
| 2005 FY | 24.96 Billion JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| American Medical Technologies Inc. | 3.19 Million USD | -1225039.23% |
| Ansell Limited | 1.61 Billion USD | -2314.624% |
| Ansell Limited | 1.61 Billion USD | -2314.624% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 184.64 Million USD | -21075.485% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 135.05 Thousand USD | -28951068.043% |
| Psykey, Inc. | 419.29 Thousand USD | -9324987.825% |
| ConvaTec Group Plc | 2.19 Billion USD | -1682.12% |
| ConvaTec Group Plc | 2.14 Billion USD | -1725.056% |
| Encision Inc. | 6.58 Million USD | -593594.208% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 1.82 Million USD | -2142453.804% |
| LifePoint, Inc. | -18.5 Thousand USD | 211351451.351% |
| Medite Cancer Diagnostics, Inc. | 6.81 Million USD | -573802.833% |
| Paradigm Medical Industries, Inc. | 772 Thousand USD | -5064666.839% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 986.22 Thousand USD | -3964532.638% |
| Reflect Scientific, Inc. | 1.08 Million USD | -3619754.206% |
| SmileDirectClub, Inc. | 470.74 Million USD | -8206.018% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.87 Billion USD | -1989.112% |
| SheerVision, Inc. | 3.49 Million USD | -1117232.165% |
| United Health Products, Inc. | - USD | -Infinity% |
| Vasamed, Inc. | 1.38 Million USD | -2820369.54% |
| Wearable Health Solutions, Inc. | 745.09 Thousand USD | -5247567.07% |
| Yubo International Biotech Limited | 104.28 Thousand USD | -37494026.559% |